M. Nikiforova

Molecular Biology · 2003–2017

A researcher in the Science corpus: 9 papers; trusts 2 researchers and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

• Molecular Biology — 79 citations into it
• Genetics — 48 citations into it
• Endocrinology, Diabetes and Metabolism — 31 citations into it; #512 of 623 by trust here, #226 by citations
• Oncology — 20 citations into it

Whom M. Nikiforova trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. K. Livak
2. Michael Mingzhao Xing
3. Robert Tibshirani
4. Yoav Benjamini
5. Mingzhao Xing
6. Thomas D. Schmittgen
7. V. Ambros
8. George A. Calin
9. Trevor J. Hastie

Who trusts M. Nikiforova overall

1. Y. Nikiforov
2. Mingzhao Xing
3. Michael Mingzhao Xing

Papers from M. Nikiforova's perspective

Ordered by how strongly the researchers M. Nikiforova trusts endorse each paper. Same corpus, a different order for every researcher.

1. Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status (Nature)
2. Mutations of the BRAF gene in human cancer (Nature)
3. BRAF mutation in papillary thyroid carcinoma. (Journal of the National Cancer Institute)
4. High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. (Cancer Research)
5. The Raf/MEK/ERK pathway: new concepts of activation (Biology of the Cell)
6. PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected]. (Science)
7. Diagnosis of multiple cancer types by shrunken centroids of gene expression
8. A microRNA expression signature of human solid tumors defines cancer gene targets (Proceedings of the National Academy of Sciences of the United States of America)
9. The functions of animal microRNAs (Nature)
10. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. (Cancer Cell)

Their papers

• Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples. (2011) — 703 citations
• Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. (2017) — 1,774 citations
• Guidelines for Validation of Next-Generation Sequencing–Based Oncology Panels (2017) — 658 citations
• Molecular genetics and diagnosis of thyroid cancer (2011) — 986 citations
• Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. (2009) — 659 citations
• MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. (2008) — 611 citations
• BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. (2003) — 1,066 citations
• RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. (2003) — 718 citations
• High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. (2003) — 1,567 citations